{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:44:52Z","timestamp":1787010292305,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:p>Lymph nodes (LNs) involved by a myelodysplastic syndrome (MDS) are rare and uncommonly biopsied. In this study, we report 6 MDS patients who underwent an LN biopsy that showed MDS, and we summarize the clinicopathologic features of this cohort. All patients presented with lymphadenopathy (generalized in 5), 5 patients had splenomegaly, and 3 patients had hepatomegaly. Histologically, the LN architecture was distorted without complete effacement. MDS cells, mostly of the myeloid lineage, produced interfollicular expansion. These myeloid cells exhibited a spectrum of maturation, and immature and atypical forms were common, including eosinophils. Scattered megakaryocytes and nucleated erythroid cells were often present. Concurrent bone marrow aspirate and biopsy specimens in these patients showed persistent\/resistant MDS. Following the diagnosis of LN involvement, patients did not respond well to therapy and all died by the time of the last follow-up, with a median survival of 6.7 months (range, 4.5 to 21.6\u2009mo). In summary, patients with MDS uncommonly develop clinically evident lymphadenopathy prompting biopsy as a result of infiltration by MDS. MDS in LNs can be subtle, showing incomplete and sometimes mild distortion of the architecture, and ancillary studies including immunohistochemical and flow cytometric immunophenotypic analysis are often needed to establish the diagnosis. These data also suggest that the emergence of lymphadenopathy attributable to MDS is associated with poor treatment response and prognosis in MDS patients and that aggressive therapy or alternative treatment regimens need to be explored in this context.<\/jats:p>","DOI":"10.1097\/pas.0000000000001689","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:55:59Z","timestamp":1614387359000},"page":"930-938","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathologic Features of Myelodysplastic Syndromes Involving Lymph Nodes"],"prefix":"10.1097","volume":"45","author":[{"given":"Hong","family":"Fang","sequence":"first","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xie","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenya","family":"Tang","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitri","family":"Krishnamurthy","sequence":"additional","affiliation":[{"name":"Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/10428199609067593","article-title":"Extramedullary myeloid cell tumors in myelodysplastic-syndromes: not a true indication of impending acute myeloid leukemia","volume":"21","author":"Byrd","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0002-9343(91)90559-G","article-title":"Granulocytic sarcoma in myelodysplastic syndromes: clinical marker of disease acceleration","volume":"90","author":"List","year":"1991","journal-title":"Am J Med"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2141.1983.tb02104.x","article-title":"Myeloid lymphoid node infiltration preceding acute myeloid leukaemia in a case of myelodysplastic syndrome","volume":"54","author":"Nielsen","year":"1983","journal-title":"Br J Haematol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/dc.10256","article-title":"Lymphnode localization of extramedullary myeloid cell tumor in myelodysplastic syndrome: report of one case diagnosed by fine-needle cytology","volume":"28","author":"Fulciniti","year":"2003","journal-title":"Diagn Cytopathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1158\/1078-0432.CCR-17-1597","article-title":"Validation of immunohistochemical assays for integral biomarkers in the NCI-MATCH EAY131 clinical trial","volume":"24","author":"Khoury","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R8-20250608","article-title":"Lymphocytic variant of hypereosinophilic syndrome: a report of seven cases from a single institution","author":"Hu","year":"2020","journal-title":"Cytometry B Clin Cytom"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jmoldx.2018.10.005","article-title":"t(3;8)(q26.2;q24) often leads to MECOM\/MYC rearrangement and is commonly associated with therapy-related myeloid neoplasms and\/or disease progression","volume":"21","author":"Tang","year":"2019","journal-title":"J Mol Diagn"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2010.28.3978","article-title":"Coalesced multicentric analysis of 2351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system","volume":"29","author":"Schanz","year":"2011","journal-title":"J Clin Oncol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1182\/blood-2012-04-423046","article-title":"Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS","volume":"120","author":"Deeg","year":"2012","journal-title":"Blood"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/modpathol.2016.75","article-title":"Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified","volume":"29","author":"Wang","year":"2016","journal-title":"Mod Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jmoldx.2018.08.002","article-title":"Ultra-rapid reporting of GENomic Targets (URGENTseq): clinical next-generation sequencing results within 48 hours of sample collection","volume":"21","author":"Patel","year":"2019","journal-title":"J Mol Diagn"},{"key":"R16-20250608","first-page":"790","article-title":"Extramedullary myeloid cell tumors. An immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections","volume":"119","author":"Roth","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0046-8177(99)90221-6","article-title":"Immunocytochemical analysis of MNDA in tissue sections and sorted normal bone marrow cells documents expression only in maturing normal and neoplastic myelomonocytic cells and a subset of normal and neoplastic B lymphocytes","volume":"30","author":"Miranda","year":"1999","journal-title":"Hum Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/PAS.0000000000000727","article-title":"Clinicopathological, cytogenetic, and prognostic analysis of 131 myeloid sarcoma patients","volume":"40","author":"Kawamoto","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"e592","DOI":"10.1038\/bcj.2017.79","article-title":"Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set","volume":"7","author":"Goyal","year":"2017","journal-title":"Blood Cancer J"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1309\/AJCPO58YWIBUBESX","article-title":"Extramedullary manifestations of myeloid neoplasms","volume":"144","author":"Wilson","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000497210","article-title":"Myeloid sarcoma","volume":"42","author":"Magdy","year":"2019","journal-title":"Oncol Res Treat"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/modpathol.3800768","article-title":"Benign extramedullary myeloid proliferations","volume":"20","author":"O\u2019Malley","year":"2007","journal-title":"Mod Pathol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000094681","article-title":"Unusual extramedullary hematopoiesis in a patient receiving granulocyte colony-stimulating factor","volume":"116","author":"Dagdas","year":"2006","journal-title":"Acta Haematol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000493752","article-title":"Extramedullary haematopoiesis in axillary lymph nodes of breast carcinoma patients receiving neoadjuvant chemotherapy: a potential diagnostic pitfall","volume":"86","author":"Badr","year":"2019","journal-title":"Pathobiology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T18:02:48Z","timestamp":1749405768000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001689","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,23]]}}}